Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03433274
Other study ID # CS0004-P
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 15, 2018
Est. completion date June 2028

Study information

Verified date May 2024
Source Abbott Medical Devices
Contact Kayla Dellefratte
Phone +1 (669)214-9748
Email SUMMIT.Trial@abbott.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 958
Est. completion date June 2028
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Symptomatic, moderate-to-severe or severe mitral regurgitation, or severe mitral annular calcification (MAC) - NYHA Functional Classification = II (if Class IV, patient must be ambulatory) - The local site heart team determines that the subject has been adequately treated per applicable standards - Not a member of a vulnerable population Exclusion Criteria: - Mitral valvular vegetation or mass - Left ventricular ejection fraction < 25% - Left ventricular end diastolic diameter > 7.0 cm - Prior surgical or interventional treatment of mitral valve involving implantation of prosthetic material - Aortic valve disease requiring surgery or transcatheter intervention - Severe tricuspid regurgitation or any tricuspid valve disease requiring surgery or transcatheter intervention - Any planned surgical / interventional procedure within 60 day prior to or following subject randomization - Subject undergoing hemodialysis due to chronic renal failure - Mitral pathoanatomy and left ventricular outflow tract anatomy deemed not suitable for Trial device implantation - Subjects with non-cardiac comorbidities that are likely to result in a life expectancy of less than 12 months

Study Design


Intervention

Device:
Tendyne Mitral Valve System
Mitral valve replacement
MitraClip System
Percutaneous mitral valve repair using the MitraClip system.

Locations

Country Name City State
Canada The Royal Victoria Hospital Montreal Quebec
Canada Montreal Heart Institute Montréal Quebec
Canada Ottawa Heart Institute Ottawa Ontario
Canada St. Michael's Hospital Toronto Ontario
Canada Sunnybrook Health Sciences Centre Toronto Ontario
United States Albany Medical College at Albany Medical Center Albany New York
United States University of Michigan Ann Arbor Michigan
United States Mission Health & Hospitals Asheville North Carolina
United States Emory University Hospital Atlanta Georgia
United States Piedmont Heart Institute Atlanta Georgia
United States University of Colorado Hospital Aurora Colorado
United States Cardiothoracic & Vascular Surgeons Austin Texas
United States Medstar Health Research Institute Baltimore Maryland
United States University of Maryland Medical Center Baltimore Maryland
United States Southside Hospital- Northwell Health Bay Shore New York
United States Princeton Baptist Medical Center Birmingham Alabama
United States UAB University Hospital Birmingham Alabama
United States St. Alphonsus Regional Medical Center Boise Idaho
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States Manatee Memorial Hospital Bradenton Florida
United States Buffalo General Hospital Buffalo New York
United States Medical University of South Carolina Charleston South Carolina
United States Carolinas Medical Center Charlotte North Carolina
United States Novant Health Heart and Vascular Research Institute Charlotte North Carolina
United States University of Virginia Medical Center Charlottesville Virginia
United States Rush University Medical Center Chicago Illinois
United States University of Cincinnati Medical Center Cincinnati Ohio
United States Morton Plant Hospital Clearwater Florida
United States The Cleveland Clinic Foundation Cleveland Ohio
United States Baylor Scott & White Heart and Vascular Hospital Dallas Texas
United States Medical City Dallas Hospital Dallas Texas
United States Delray Medical Center Delray Beach Florida
United States Henry Ford Hospital Detroit Michigan
United States Inova Fairfax Hospital Falls Church Virginia
United States Fresno Heart Hospital Fresno California
United States North Florida Regional Medical Center Gainesville Florida
United States Shands at the University of Florida Gainesville Florida
United States Hackensack University Medical Center Hackensack New Jersey
United States Memorial Hermann Hospital Houston Texas
United States St. Vincent Hospital Indianapolis Indiana
United States St. Luke's Hospital Kansas City Missouri
United States Baptist Health Medical Center Little Rock Arkansas
United States Cedars-Sinai Medical Center Los Angeles California
United States University of Southern California University Hospital Los Angeles California
United States Catholic Medical Center Manchester New Hampshire
United States Wellstar Kennestone Hospital Marietta Georgia
United States Baptist Memorial Hospital Memphis Tennessee
United States Baptist Hospital of Miami Miami Florida
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Abbott Northwestern Hospital Minneapolis Minnesota
United States The International Heart Institute of Montana Missoula Montana
United States West Virginia University Morgantown West Virginia
United States Centennial Medical Center Nashville Tennessee
United States St. Thomas Hospital Nashville Tennessee
United States Robert Wood Johnson University Hospital New Brunswick New Jersey
United States Lenox Hill Hospital New York New York
United States New York Presbyterian Hospital/ Weill Cornell Medical Center New York New York
United States Newark Beth Israel Medical Center Newark New Jersey
United States Advocate Christ Medical Center Oak Lawn Illinois
United States Banner-University Medical Center Phoenix Arizona
United States Alleghany General Hospital - ASRI Pittsburgh Pennsylvania
United States UPMC Shadyside Pittsburgh Pennsylvania
United States Providence Heart & Vascular Institute Portland Oregon
United States Mayo Clinic Rochester Minnesota
United States Beaumont Hospital Royal Oak Michigan
United States Sutter Medical Center, Sacramento Sacramento California
United States University of California - Davis Medical Center Sacramento California
United States St. Louis University Hospital Saint Louis Missouri
United States San Diego Cardiac Center San Diego California
United States University of California at San Francisco San Francisco California
United States HonorHealth Scottsdale Shea Medical Center Scottsdale Arizona
United States Swedish Medical Center - Heart & Vascular Seattle Washington
United States Adventist HealthCare White Oak Medical Center Silver Spring Maryland
United States Prairie Education & Research Cooperative Springfield Illinois
United States Stanford Health Care Stanford California
United States Tallahassee Research Institute Tallahassee Florida
United States Los Robles Hospital and Medical Center Thousand Oaks California
United States Oklahoma Heart Institute at Utica Tulsa Oklahoma
United States Cleveland Clinic Florida Weston Florida
United States Cardiovascular Research Institute of Kansas Wichita Kansas

Sponsors (1)

Lead Sponsor Collaborator
Abbott Medical Devices

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Randomized Cohort Survival free of heart failure hospitalization at 12 months post index procedure 1 year
Primary Non-repairable Cohort Survival free of heart failure hospitalization at 12 months post index procedure 1 year
Primary Severe Mitral Annular Calcification (MAC) Cohort Survival free of heart failure hospitalization at 12 months post index procedure 1 year
Primary Severe MAC Continued Access Protocol (MAC CAP) Cohort Survival free of heart failure hospitalization at 12 months post index procedure 1 year
Secondary Change from baseline in distance walked, as measured by the 6 Minute Walk Test (6MWT) 1 year
Secondary Change from baseline in quality of life, as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) 1 year
Secondary Change from baseline in health outcomes, as measured by the EQ-5D 1 year
Secondary • Change from baseline in health outcomes, as measured by the 12-item Short Form Health Survey (SF-12) 1 year
Secondary Change from baseline in New York Heart Association Classification 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)